164 related articles for article (PubMed ID: 25111434)
1. Bis-quaternary gemini surfactants as components of nonviral gene delivery systems: a comprehensive study from physicochemical properties to membrane interactions.
Cardoso AM; Morais CM; Silva SG; Marques EF; de Lima MC; Jurado MA
Int J Pharm; 2014 Oct; 474(1-2):57-69. PubMed ID: 25111434
[TBL] [Abstract][Full Text] [Related]
2. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
[TBL] [Abstract][Full Text] [Related]
3. New serine-derived gemini surfactants as gene delivery systems.
Cardoso AM; Morais CM; Cruz AR; Silva SG; do Vale ML; Marques EF; de Lima MC; Jurado AS
Eur J Pharm Biopharm; 2015 Jan; 89():347-56. PubMed ID: 25513958
[TBL] [Abstract][Full Text] [Related]
4. Modulation of pyridinium cationic lipid-DNA complex properties by pyridinium gemini surfactants and its impact on lipoplex transfection properties.
Sharma VD; Lees J; Hoffman NE; Brailoiu E; Madesh M; Wunder SL; Ilies MA
Mol Pharm; 2014 Feb; 11(2):545-59. PubMed ID: 24377350
[TBL] [Abstract][Full Text] [Related]
5. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
6. Structural, biocomplexation and gene delivery properties of hydroxyethylated gemini surfactants with varied spacer length.
Zakharova LY; Gabdrakhmanov DR; Ibragimova AR; Vasilieva EA; Nizameev IR; Kadirov MK; Ermakova EA; Gogoleva NE; Faizullin DA; Pokrovsky AG; Korobeynikov VA; Cheresiz SV; Zuev YF
Colloids Surf B Biointerfaces; 2016 Apr; 140():269-277. PubMed ID: 26764110
[TBL] [Abstract][Full Text] [Related]
7. Interactions between DNA and gemini surfactant: impact on gene therapy: part II.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(4):403-20. PubMed ID: 26784450
[TBL] [Abstract][Full Text] [Related]
8. Gemini surfactants mediate efficient mitochondrial gene delivery and expression.
Cardoso AM; Morais CM; Cruz AR; Cardoso AL; Silva SG; do Vale ML; Marques EF; Pedroso de Lima MC; Jurado AS
Mol Pharm; 2015 Mar; 12(3):716-30. PubMed ID: 25634573
[TBL] [Abstract][Full Text] [Related]
9. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
[TBL] [Abstract][Full Text] [Related]
10. [12]aneN
Ma LL; Tang Q; Liu MX; Liu XY; Liu JY; Lu ZL; Gao YG; Wang R
ACS Appl Mater Interfaces; 2020 Sep; 12(36):40094-40107. PubMed ID: 32805811
[TBL] [Abstract][Full Text] [Related]
11. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
[TBL] [Abstract][Full Text] [Related]
12. Syntheses, transfection efficacy and cell toxicity properties of novel cholesterol-based gemini lipids having hydroxyethyl head group.
Biswas J; Mishra SK; Kondaiah P; Bhattacharya S
Org Biomol Chem; 2011 Jun; 9(12):4600-13. PubMed ID: 21537498
[TBL] [Abstract][Full Text] [Related]
13. Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies.
Donkuru M; Badea I; Wettig S; Verrall R; Elsabahy M; Foldvari M
Nanomedicine (Lond); 2010 Sep; 5(7):1103-27. PubMed ID: 20874024
[TBL] [Abstract][Full Text] [Related]
14. Tuning optimum transfection of gemini surfactant-phospholipid-DNA nanoparticles by validated theoretical modeling.
Taheri-Araghi S; Chen DW; Kohandel M; Sivaloganathan S; Foldvari M
Nanoscale; 2019 Jan; 11(3):1037-1046. PubMed ID: 30569915
[TBL] [Abstract][Full Text] [Related]
15. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
Gharagozloo M; Rafiee A; Chen DW; Foldvari M
J Nanobiotechnology; 2015 Sep; 13():62. PubMed ID: 26415935
[TBL] [Abstract][Full Text] [Related]
16. Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA.
Maslov MA; Kabilova TO; Petukhov IA; Morozova NG; Serebrennikova GA; Vlassov VV; Zenkova MA
J Control Release; 2012 Jun; 160(2):182-93. PubMed ID: 22138073
[TBL] [Abstract][Full Text] [Related]
17. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
Narsineni L; Foldvari M
Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
[TBL] [Abstract][Full Text] [Related]
18. Peptide-Modified Gemini Surfactants: Preparation and Characterization for Gene Delivery.
Al-Dulaymi M; Mohammed-Saeid W; El-Aneed A; Badea I
Methods Mol Biol; 2019; 2000():203-225. PubMed ID: 31148017
[TBL] [Abstract][Full Text] [Related]
19. Structure-delivery relationships of lysine-based gemini surfactants and their lipoplexes.
Damen M; Cristóbal-Lecina E; Sanmartí GC; van Dongen SF; García Rodríguez CL; Dolbnya IP; Nolte RJ; Feiters MC
Soft Matter; 2014 Aug; 10(31):5702-14. PubMed ID: 24969740
[TBL] [Abstract][Full Text] [Related]
20. Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated
Massa M; Rivara M; Donofrio G; Cristofolini L; Peracchia E; Compari C; Bacciottini F; Orsi D; Franceschi V; Fisicaro E
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
